Within 24 hours of last week, an expert committee from the national drug regulator changed its decision on whether Bharat Biotech’s Covid-19 candidate vaccine could be recommended for approval without evidence of its efficacy in humans, the minutes of the committee meetings held on January 1 and 2 show. The …
Read More »
An expert panel from India’s top drug regulator on Saturday recommended restricted emergency approval for Covaxin, Bharat Biotech’s Covid-19 candidate vaccine currently being tested in the country. The panel of experts now recommended a restricted authorization for two candidate vaccines in as many days; on Friday, it recommended similar approval …
Read More »
An expert panel from India’s central drug authority on Saturday recommended granting permission for the restricted use of the indigenous COVID-19 vaccine developed by Bharat Biotech Covaxin in an emergency situation, especially in the context of infection by mutant strains, authorities said. The recommendation for the Bharat Biotech vaccine came …
Read More »